Vaxart, Inc. (VXRT)
0.631
-0.11
(-14.38%)
USD |
OTCM |
Mar 13, 16:00
Vaxart Total Liabilities (Quarterly) : 98.28M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 51.59M |
| Nuwellis, Inc. | 3.488M |
| Capricor Therapeutics, Inc. | -- |
| Allogene Therapeutics, Inc. | 123.36M |
| Silvergate Capital Corp. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 186.08M |
| Shareholders Equity (Quarterly) | 87.80M |
| Debt to Equity Ratio | 0.1486 |
| Current Ratio | 1.603 |
| Net Debt Paydown Yield | 2.41% |